Evidence map›Paper›PMID 41815633›Full record

ArticleEndocrine oncology (Bristol, England)2026

Physical activity and systemic treatment outcomes in advanced thyroid cancer.

Carla Colombo, Daniele Ceruti, Fabrizio Cervellini, Massimiliano Succi, Simone De Leo, Matteo Trevisan, Claudia Moneta, Marina Lugaresi, Gianlorenzo Dionigi, Giacomo Gazzano and 2 more

Abstract read
In one paragraph

Article in Endocrine oncology (Bristol, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carla ColomboDepartment of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0003-0716-481X
Daniele CerutiDepartment of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Fabrizio CervelliniDepartment of Sports Science, University of Milan, Milan, Italy.
Massimiliano SucciDepartment of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Simone De LeoDepartment of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Matteo TrevisanDepartment of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Claudia MonetaDepartment of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Marina LugaresiDepartment of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Gianlorenzo DionigiDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Giacomo GazzanoPathology Unit, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Luca PersaniDepartment of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Laura FugazzolaEndocrinology Division, ASST Santi Paolo e Carlo, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Physical activity interventions could play a critical role in tolerance and outcome during anti-neoplastic therapy. Aim: This study aims to evaluate the role of physical activity and its maintenance on treatment safety and efficacy in patients with advanced thyroid cancer. Methods: We enrolled 28 patients with advanced thyroid cancer, treated with kinase inhibitor therapy for a median follow-up of 26 months. Three modified long-form International Physical Activity Questionnaires were administered before treatment, at an intermediate follow-up point and at the last follow-up point. Metabolic equivalents were calculated at each time point. Tumour response was evaluated according to RECIST, version 1.1. Results: Patients inactive at baseline experienced more treatment interruptions during both the first (85 vs 30%, Conclusion: This is the first study showing that maintaining adequate physical activity levels is associated with better treatment tolerance and outcomes in advanced thyroid cancer patients on kinase inhibitor therapy, supporting the need for prospective prehabilitation trials.

Indexed as

kinase inhibitor therapyphysical activityprehabilitationthyroid cancer

Identifiers

PMID41815633
PMCPMC12974739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.